Symbols

Endra Life Sciences Soars 29.17% on Zacks Rank Upgrade

Generated by AI AgentAinvest Movers Radar

Wednesday, Apr 30, 2025 4:21 am ET1min read

On April 30, 2025, Endra Life SciencesNDRA-- surged 29.17% in pre-market trading, marking a significant rise in its stock value.

Endra Life Sciences has been upgraded to a Zacks Rank #1 (Strong Buy), indicating a growing optimism about the company's earnings prospects. This upgrade reflects the market's positive outlook on the company's future performance.

Analysts have set a 12-month price target for Endra Life Sciences, predicting a substantial increase from the current stock price. This target suggests that the company is expected to experience significant growth in the coming year.

Ainvest Movers Radar

Knowing stock market today at a glance

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments

﻿

Add a public comment...

No comments yet

AInvest
PRO

Editorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process. While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context. Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue